Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer

Dual-port laparoscopic gastrectomy (DPLG) has been widely performed in recent years for treating gastric cancers. The present study explore the safety and effect of dual-port laparoscopic distal gastrectomy (DPLDG).

Trial Details

NCT ID
NCT05494086
Phase
NA
Sponsor
Nanfang Hospital, Southern Medical University
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • DPLDG
  • LDG
Locations (sample)
  • Guangzhou, Guangdong, China|23.11667,113.25

Key Eligibility Criteria

  • patients within 18--75 years old;
  • patients with a preoperative pathological diagnosis of gastric adenocarcinoma;
  • patients with a clinical tumor stage of T1N1,T2N0 according to the preoperative examinations (gastroscopy, ultrasound gastroscopy and computed tomo…
  • patients with a plan to undergo laparoscopic distal gastrectomy and obtain R0 surgical results;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →